Bombshell: Prosecutors Question Timing of Pfizer Announcement Released Just After 2020 Election

Just two days after Democrat Joe Biden was declared the winner of the 2020 presidential election, drugmaker Pfizer announced its COVID-19 vaccine proved effective in protecting people from the sickness.

Then-President Donald Trump questioned the timing of the announcement, saying, “Pfizer and others even decided to not assess the results of their vaccine, in other words, not come out with the vaccine until just after the election.”

He suggested the delay was payback for Trump’s effort to rein in the cost of medications for elderly patients.

“[It’s] because of what I did with favored nations and these other elements,” he said.

In September 2020, Trump signed an executive order benchmarking the price Americans pay through Medicare for prescription drugs to the cost of those same drugs in other markets outside the U.S.

Trump asserted that the original plan called for the COVID vaccine data to be released in October.

Pfizer’s CEO Albert Bourla, in fact, told NBC’s “Today” at the time that his company would know whether the vaccine worked by the end of October.

Keep reading

Pfizer CEO Flops Attempting to Defend Vax Liability Shield

The very simple — and unexpected, coming from CNBC, which usually runs cover for pharmaceutical corporations as a matter of course — question posed to Albert Bourla:

Vaccine makers like yourself [are] largely shielded from liability. If the products are safe and effective, what is the need to continue to shield, to have these liability shields, and what happens if those shields are changed or go away completely?

The very simple answer, assuming the vaccines are actually “safe and effective,” would be: “Nothing happens if we lose our liability shield. We don’t need it because our product is safe and effective, and we are willing to prove that in court if need be.”

That’s not what Bourla said. Instead, he offered a word salad about how the trustworthy FDA would never approve a dangerous and ineffective vaccine. Therefore, by virtue of the fact that the FDA allowed the COVID shots to go to market, they are by definition “safe and effective.”

Also, he adds, American juries are too stupid to decide whether an injury was caused by a vaccine or a car accident.

If the product is not safe and effective, it would never get approval from the FDA or from the other health authorities… They are very strict when they are approving products, particularly for vaccines… However, in a system that litigations can flourish, anyone can create, demand that the accident in the car happened because of the vaccine, and uh, with a jury, it’s going to be flip of the coin. And this is, I think, why the Congress — it was not an administration — had passed this legislation that is protecting those that they have approval from the FDA from federal liabilities.

Keep reading

Pfizer hires ex-FDA drug chief as top doctor

The former head of the Food and Drug Administration’s (FDA) drug division is joining Pfizer as its chief medical officer, the company announced Monday. 

Patrizia Cavazzoni was formerly director of the FDA’s Center for Drug Evaluation and Research (CDER) from 2020 until January, when she resigned just ahead of President Trump’s return to office. 

Cavazzoni previously worked at Pfizer prior to joining the FDA in 2018.  

The announcement spurred renewed criticisms about the common “revolving door” between the FDA and industry. Critics worry the close relationship leads to a quid pro quo and favoritism toward industry.

Robert Califf, who served as FDA commissioner under President Obama, left the agency to advise Google Health and its spinoff, Verily Life Sciences. The move garnered criticism and opposition from some Senate Democrats like Sen. Elizabeth Warren (D-Mass.) when President Biden nominated him for the same job.

Keep reading

FDA Misled The Judiciary About Pfizer’s Vaccine Documents

On December 6, 2024, a federal judge ordered the US Food and Drug Administration (FDA) to release documents related to the emergency use authorisation of Pfizer’s Covid-19 vaccine. These documents had been hidden from public view.

The legal battle traces back to September 2021, when attorney Aaron Siri filed a lawsuit under the Freedom of Information Act (FOIA) on behalf of the Public Health and Medical Professionals for Transparency. The plaintiffs sought access to the vast trove of documents the FDA relied on to approve Pfizer’s vaccine.

Initially, the FDA proposed a slow release schedule. In November 2021, the agency stated it would release just 500 pages per month—a pace that would have stretched the full disclosure process to 75 years. 

However, in January 2022, District Judge Mark Pittman of Texas rejected the FDA’s proposal, ordering the agency to expedite its release to 55,000 pages per month, aiming to complete the disclosure of all 450,000 pages by August 2022.

As the documents trickled out, researchers began uncovering glaring gaps that prevented a systematic review of the data. These gaps fueled suspicions about what else the FDA might be withholding. 

It became evident that the FDA had withheld records directly tied to its emergency use authorisation of Pfizer’s vaccine, estimated to be over one million pages. 

These documents, which the FDA had full knowledge of, were excluded from earlier disclosures, effectively misleading the judiciary and undermining public trust.

Keep reading

Pfizer Agrees to $60 Million Settlement in Kickback Scandal for Allegedly ‘Bribing’ Doctors to Promote Migraine Drug — Defrauding Medicare and Other Federal Health Programs

Big Pharma Pfizer has agreed to a hefty $59.7 million settlement to resolve allegations of a kickback scandal that has defrauded Medicare and other federal healthcare programs.

The scandal revolves around Biohaven Pharmaceutical, a company acquired by Pfizer in October 2022, which engaged in unethical practices to push prescriptions of its migraine medication, Nurtec ODT, also known as Rimegepant.

Whistleblower Patricia Frattasio, a former sales representative at Biohaven, played a crucial role in bringing these malpractices to light, leading to a qui tam lawsuit under the False Claims Act in 2021.

The U.S. Department of Justice disclosed that from March 2020 through September 2022, Biohaven manipulated the healthcare system by offering kickbacks—including speaker honoraria and lavish meals at upscale restaurants—to healthcare professionals.

Allegations include that Biohaven paid some healthcare providers over $100,000 to boost prescriptions of their migraine medication, Nurtec ODT, resulting in fraudulent claims to federal programs like Medicare and Medicaid.

This egregious scheme involved not just ordinary incentives, but also repeated, unnecessary educational programs that offered no real benefit to attendees, turning these events into mere facades for bribery.

This practice, aimed at increasing Nurtec ODT prescriptions, breached anti-kickback statutes designed to keep medical decisions free from financial influence.

Keep reading

Official Czech Republic record level data released Nov 2024 confirms Moderna has nearly 50% higher ACM than Pfizer

AFAIK, for the first time in human history a government has voluntarily released vaccine record-level data, the “gold standard” for vaccine safety analysis.

Woo hoo!

It shows the Moderna vaccine is unsafe. And based on other data, Pfizer is too.

The data and the analysis

Here it is: the Czech Republic record level data (1.3GB in size).

Since no epidemiologist in the world is analyzing this data (since it would be a career-limiting move), I guess it’s up to me to tell you what it says.

So I wrote about 150 lines of Python code to analyze it and you can download the summary spreadsheet here and take a look at what I found.

Basically, Moderna is a disaster. It increases All Cause Mortality (ACM) by around 50% relative to Pfizer, and that’s in non-COVID periods. So even if Pfizer is perfectly safe (it isn’t), Moderna should be immediately halted.

Keep reading

UK Doctors Group That Pushed COVID Shots for Teens Hid Payments From Pfizer

The U.K.’s Royal College of General Practitioners (GP) failed to declare payments it received from Pfizer while it was advocating that children be given the COVID-19 vaccine, The Telegraph reported last week.

The Royal College of GPs, which represents 54,000 GPs, is the U.K.’s professional body for general medical practitioners, similar to the American Medical Association in the U.S.

In 2021, Pfizer gave the organization 102,820 British pounds ($125,558 USD at current exchange rates) through “donations and grants” and “benefits in kind.” That was more than double the 49,324 pounds ($60,232) Pfizer gave the organization in 2020, up from only 4,309 pounds ($5,262) in 2019.

In September 2021, the U.K.’s chief medical officers, the highest-ranking government public health advisers, asked parents to vaccinate their children to keep schools open, according to The Telegraph.

They issued that advice even though the Joint Committee on Vaccination and Immunisation (JCVI), which advises the government on vaccination, opted not to recommend universal vaccination for 12- to 15-year-olds. The JCVI said the benefits of vaccination for that age group were only “marginally greater than the potential known harms.”

Keep reading

FDA Orders Pfizer to Add PARALYSIS WARNING to RSV Vaccine Labels

Last Wednesday, the FDA ordered Pfizer and GSK to add Guillain-Barre Syndrome (GBS) as a serious adverse event risk warning to both Pfizer’s Abrysvo and GSK’s Arexy Respiratory Syncytial Virus (RSV) vaccine labels.

RSV is the leading cause of respiratory infection in adults over the age of 60. Prior to 2023, the CDC has not published data on the incidence of RSV death in babies and children. In 2023, the CDC estimates that approximately 100 children under the age of 5 died from RSV. Despite these low numbers, the CDC recommends that pregnant women receive an RSV vaccine to ‘protect’ their baby from RSV.

Keep reading

Pfizer’s secret documents reveal that their COVID vaccine actually made you 8.7% more likely to get COVID

Pfizer tested all participants in their Phase 3 trial for N-antibodies. The results were kept hidden from the public. It was only through court order that we finally know what the results were.

Do you think they would have kept this data secret from the public if it showed good news? Heck no!

The table showed that Pfizer only had around 50% protection if you just take the table at face value. But if you interpret the table correctly, it shows Pfizer had negative efficacy.

In this article, I’ll show you how to properly interpret that data and get the truth.

The method was first disclosed by Jikkyleaks on May 24, 2022.

I recently became aware of it after independently replicating his work. I believe his numbers are slightly off, so I’ll show you the proper calculation for the correct estimate of the case counts.

No doubt about it; those who took the shots were more likely to be infected by COVID by 8.7%.

There is just no other way to interpret the Pfizer data. It’s “gold standard” clinical trial data.

The overall counts are too small for the result to be statistically significant. But the FDA should NEVER be approving a vaccine where the primary endpoint efficacy (reducing cases vs. the unvaccinated group) is so small to be statistically insignificant.

In plain English, the best estimates are that there were actually more infections in the vaccine group than the placebo group. Whoops!

This is a major failing of the FDA to recognize this.

It won’t be long before Senator Ron Johnson brings this to their attention.

Keep reading

FDA’s Own Study Finds DNA Contamination in Pfizer Vaccines

peer-reviewed study performed at a U.S. Food and Drug Administration (FDA) laboratory by high school students has confirmed the presence of a high level of DNA contamination in Pfizer’s mRNA COVID-19 vaccine.

The study, published Dec. 29, 2024, in the Journal of High School Science, was authored by three students at Centreville High School in Clifton, Virginia, and performed under the supervision of FDA scientists.

Maryanne Demasi, Ph.D., an investigative medical reporter, was the first to report on the study.

The research, performed at the FDA’s White Oak Campus in Maryland, found that levels of residual DNA in the Pfizer COVID-19 vaccine were 6 to 470 times higher than regulatory safety limits. The students tested two lots of the vaccine, finding they contained “residual DNA to a level that exceeds 10 ng [nanograms] per dose.”

“The potential health risk posed by residual small DNA fragments is currently unknown,” the study stated. However, the authors also said that DNA contamination may result in insertional mutagenesis — or DNA mutations — that can cause cancer.

Speaking last month on “The Defender In-Depth,” Kevin McKernan, who first identified DNA contamination in the shots in 2023, said DNA in vaccines can pose health risks because the DNA “could integrate into the genome and cause disruption of the genome … or it could disrupt other genes that are related to cancer.”

The FDA did not respond to multiple requests for comment on the study.

Keep reading